Altimmune is a clinical-stage biopharmaceutical company focused on developing peptide-based treatments for obesity and liver diseases. Their lead drug candidate, Pemvidutide, targets glucagon-like ...

“Significant untapped growth potential,” touts a slide in an Offerpad Solutions Inc. presentation to investors in the blank-check SPAC that took the company public in 2020. Offerpad is an instant ...

AI disruption is coming faster than most expect. It could reshape jobs, wealth, and markets like nothing since the Industrial Revolution. The American Dream is under pressure as inflation, inequality, ...

Building and scaling businesses is rarely plain sailing. No matter how well you know your industry, market disruptions and other events can threaten the well-being of your organization. On the other ...

RANCHO PALOS VERDES, CA / ACCESS Newswire / August 13, 2025 / NBJ Summit 2025, the nutrition and dietary supplements industry's flagship invite-only event hosted by New Hope Network, wrapped up four ...

The embedded subscriber identity module (eSIM) industry has seen huge growth and uptake by leading firms in the sector over the past year, and this accelerating adoption is poised to reshape the ...

Diabetes is certainly making a name for itself these days. In 2023 two events supercharged the category and could radically change the treatment for the 38 million Americans—11.6% of the ...

FRANKFURT, Nov 17 - Shares in German kidney dialysis company Fresenius Medical Care (FMEG.DE), opens new tab (FMC) rose on Friday after Societe Generale said that disruption of the dialysis market by ...

At Palantir Technologies Inc.’s (NYSE:PLTR) recent earnings call, company CEO Alex Karp proclaimed, “AIP and U.S. commercial, not only is disrupting the market, it’s setting a standard that I don’t ...